Summary
Responses and susceptibility of 14 human glioblastoma cell lines to human natural tumor necrosis factor-α (TNF) were studiedin vitro.
Susceptibility of glioblastoma cells to TNF varied in experimental conditions applied. Most of glioblastoma cell lines were resistant to cytotoxic activity of TNF in a MTT assay at concentrations below 16U/ml for 72 h exposure. However, TNF at higher dose, in prolonged exposure and against low density of target cells was antiproliferative for certain glioblastoma cultures. TNF exposure at 10U/ml for 48 h suppressed DNA synthesis in 9 of 14 glioblastoma cultures, but increased in 3 cultures. In addition, colony forming assay showed anti-clonogenic activity of TNF in 5 of 6 glioblastoma cell lines tested.
In spite of their low susceptibility to TNF, glioblastoma cells well responded to TNF stimulation at low dose (10U/ml) for a short period in the absence of cell damage. Productions of Interleukin-6 (IL-6), IL-8-like activity, granulocyte-macrophage colony stimulating factor (GM-CSF), prostaglandin E2 (PGE2) and manganous Superoxide dismutase (Mn-SOD) were enhanced or induced by the low-dose TNF stimulation.
Mn-SOD, a protein protective against oxidative cell damage, was well induced in time- and dose-dependent manner, however did not correlate with TNF resistance. Whereas the levels of PGE2 in TNF-susceptible cell lines, H-4 and SF-188, were higher than those of other lines.
In conclusion, most of glioblastoma cells are resistant to TNF cytotoxic effects, but highly responsive to TNF stimulation. Its effect on glioblastoma cells appears to modulate cell differentiation rather than to kill the cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rutka JT, Giblin JR, Berens ME, Bar-Shiva E, Tokuda K, McCulloch JR, Rosenblum ML, Eessalu TE, Aggarwal BB, Bodell WJ: The effect of human recombinant tumor necrosis factor on glioma-derived cell line, cellular proliferation, cytotoxicity, morphological and radioreceptor studies. Int J Cancer 41: 573–582, 1988
Zuber P, Accolla RS, Carrel S, Diserens AC, de Tribolet N: Effects of recombinant human tumor necrosis factor-α on the surface phenotype and the growth of human malignant glioma cell lines. Int J Cancer 42: 780–786, 1988
Helseth E, Torp S, Dalen A, Unsgaard G: Effect of interferon-gamma and tumor necrosis factor alpha on clonogenic growth of cell lines and primary cultures from human gliomas and brain metastasis. APMIS 97: 569–574, 1989
Selmaji KW, Farooq M, Norton WT, Raine CS, Brosnan CF: Proliferation of astrocytesin vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol 144: 129–135, 1990
Lachman LB, Brown DC, Dinarrello CA: Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line. J Immunol 138: 2913–2916, 1987
Bethea JR, Gillespie GY, Chung IY, Benveniste EN: Tumor necrosis factor production and receptor expression by a human malignant glioma cell line, D54-MG. J Neuroimmunol 30:1–13, 1990
Neal ML, Fiera A, Matthews N: Involvement of phospholipase A2 activation in tumour cell killing by tumour necrosis factor. Immunology 64: 81–85, 1988
Zimmerman RJ, Marafino BJ, Chan Jr A, Landre P, Winkelhake JL: The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factorin vivo. Implication for mechanism of action. J Immunology 142: 1405–1409, 1989
Wong GHW, Goeddel D: Induction of manganous superoxide dismutase by tumor necrosis factor: Possible protective mechanism. Science 242: 941–944, 1988
Wong GHW, Elwell JH, Oberly LW, Goeddel DV: Manganous Superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58: 923–931, 1989
Del Maestro RF, Lopez-Torres M, McDonald WB, Stroude EC, Vaithilingam IS: The effect of tumor necrosis factor-α on human malignant glial cells. J Neurosurg 76: 652–659, 1992
Munker R, Gasson J, Ogawa M, Koeffler HP: Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature 323: 79–82, 1986
Malipiero UV, Frei K, Fontana A: Production of hemopoietic colony-stimulating factor by astrocytes. J Immunol 144: 3816–3821, 1990
Van Meir E, Sawamura Y, Diserens AC, Hamou MF, de Tribolet N: Human glioblastoma cells release interleukin 6in vivo andin vitro. Cancer Res 50: 6683–6688, 1990
Wesselingh SL, Gough NM, Finlay-Jones JJ, McDonald PJ: Detection of cytokine mRNA in astrocyte cultures using the polymerase chain reaction. Lymphokine Res 9: 177–185, 1990
Kuppner MC, van Meir E, Hamou MF, de Tribolet N: Cytokine regulation of intercellular adhesion molecule-1 (ICAM-1) expression on human glioblastoma cells. Clin Exp Immunol 81:142–148, 1990
Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J Immunol Methods 65: 55–63, 1983
Aida T, Bodell WJ: Cellular resistance to chloroethylnitroso-ureas, nitrogen mustard, and cis-diamminedichloroplatinum (II) in human glial-derived cell lines. Cancer Res 47: 1361–1366, 1987
Kawaguchi T, Suzuki K, Matsuda Y, Nishiura T, Uda T, Ono M, Sekiya C, Ishikawa M, Iino S, Endo Y, Taniguchi N: Serum-manganese Superoxide dismutase: normal values and increased levels in patients with acute myocardial infarction and several malignant disease determined by an enzymelinked immunosorbent assay using a monoclonal antibody. J Immunol Methods 127: 249–254, 1990
Suzuki K, Miyasaka H, Ota H, Yamakawa Y, Tagawa M, Kuramoto A, Mizuno S: Purification and partial primary sequence of a chemotactic protein for cell carcinoma LU65C cells. J Exp Med 169:1895–1901, 1989
Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino Jr MA, Shepard HM: Recombinant human tumor necrosis factor-α: effect on proliferation of normal and transformed cellin vitro. Science 230: 943–945, 1985
Blick M, Sherwin SA, Rosenblum M, Gutterman J: Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 47: 2986–2989, 1987
Tada M, Sawamura Y, Sakuma S, Suzuki K, Ohta H, Aida T, Abe H: Cellular and cytokine responses in the human central nervous system to intracranial administration of tumor necrosis factor-α for the treatment of malignant gliomas. Cancer Immunol Immunother (accepted)
Nio Y, Zighelboim J, Berek J, Bonavida B: Cyclohexamideinduced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells. Cancer Chemother Pharmacol 26:1–8, 1990
Reid TR, Torti FM, Ringold GM: Evidence for two mechanisms by which tumor necrosis factor kills cell. J Biol Chem 264: 4583–4589, 1989
Kawaguchi T, Takeyasu A, Matsunobu K, Uda T, Ishizawa M, Suzuki K, Nishiura T, Ishikawa M, Taniguchi N: Stimulation of Mn-superoxide dismutase expression by tumor necrosis factor-α: quantitative determination of Mn-SOD protein level in TNF-resistant and sensitive cells by ELISA. Biochem Biophys Res Commun 171:1378–1386, 1990
Fontana A, Hengartner H, de Tribolet N, Weber E: Glioblastoma cell release IL-1 and factor inhibiting IL-2 mediated effects. J Immunol 132:1837–1844, 1984
Grunfeld C, Palladino MA Jr: Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities. Adv Intern Med 35: 45–72, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sakuma, S., Sawamura, Y., Tada, M. et al. Responses of human glioblastoma cells to human natural tumor necrosis factor-α: Susceptibility, mechanism of resistance and cytokine production studies. J Neuro-Oncol 15, 197–208 (1993). https://doi.org/10.1007/BF01050066
Issue Date:
DOI: https://doi.org/10.1007/BF01050066